These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 20032228

  • 1. Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
    Stratta P, Canavese C, Quaglia M, Fenoglio R.
    Rheumatology (Oxford); 2010 Apr; 49(4):821-3. PubMed ID: 20032228
    [No Abstract] [Full Text] [Related]

  • 2. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN.
    J Assoc Physicians India; 2008 Nov 01; 56():915-6. PubMed ID: 19263697
    [No Abstract] [Full Text] [Related]

  • 4. Focus on contrast-associated nephrogenic systemic fibrosis.
    Partain CL.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1231-2. PubMed ID: 19938033
    [No Abstract] [Full Text] [Related]

  • 5. Special issue: nephrogenic systemic fibrosis.
    Leiner T, Kucharczyk W.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1233-5. PubMed ID: 19938034
    [No Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.
    Wang SC.
    J Med Imaging Radiat Oncol; 2008 Aug 01; 52(4):305-6. PubMed ID: 18811752
    [No Abstract] [Full Text] [Related]

  • 7. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
    Abraham JL, Edward M.
    AJR Am J Roentgenol; 2009 Oct 01; 193(4):W354; author reply W355. PubMed ID: 19770307
    [No Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor.
    Lu CF, Hsiao CH, Tjiu JW.
    J Eur Acad Dermatol Venereol; 2009 Mar 01; 23(3):339-40. PubMed ID: 18573157
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gadolinium and systemic fibrosis: guilt by association.
    Kay J, Czirják L.
    Ann Rheum Dis; 2010 Nov 01; 69(11):1895-7. PubMed ID: 20959325
    [No Abstract] [Full Text] [Related]

  • 12. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
    Gupta A, Shamseddin MK, Khaira A.
    Clin Exp Dermatol; 2011 Oct 01; 36(7):763-8. PubMed ID: 21790732
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?
    Lind Ramskov K, Thomsen HS.
    Acta Radiol; 2009 Nov 01; 50(9):965-7. PubMed ID: 19863403
    [No Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec 01; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct 01; 17(97):205. PubMed ID: 19537311
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K, Maeda T, Watanabe S, Ueno Y, Sugimura K.
    Int J Urol; 2012 Sep 01; 19(9):806-11. PubMed ID: 22571387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.